Surgical ablation of atrial fibrillation during mitral-valve surgery.

BACKGROUND Among patients undergoing mitral-valve surgery, 30 to 50% present with atrial fibrillation, which is associated with reduced survival and increased risk of stroke. Surgical ablation of atrial fibrillation has been widely adopted, but evidence regarding its safety and effectiveness is limited. METHODS We randomly assigned 260 patients with persistent or long-standing persistent atrial fibrillation who required mitral-valve surgery to undergo either surgical ablation (ablation group) or no ablation (control group) during the mitral-valve operation. Patients in the ablation group underwent further randomization to pulmonary-vein isolation or a biatrial maze procedure. All patients underwent closure of the left atrial appendage. The primary end point was freedom from atrial fibrillation at both 6 months and 12 months (as assessed by means of 3-day Holter monitoring). RESULTS More patients in the ablation group than in the control group were free from atrial fibrillation at both 6 and 12 months (63.2% vs. 29.4%, P<0.001). There was no significant difference in the rate of freedom from atrial fibrillation between patients who underwent pulmonary-vein isolation and those who underwent the biatrial maze procedure (61.0% and 66.0%, respectively; P=0.60). One-year mortality was 6.8% in the ablation group and 8.7% in the control group (hazard ratio with ablation, 0.76; 95% confidence interval, 0.32 to 1.84; P=0.55). Ablation was associated with more implantations of a permanent pacemaker than was no ablation (21.5 vs. 8.1 per 100 patient-years, P=0.01). There were no significant between-group differences in major cardiac or cerebrovascular adverse events, overall serious adverse events, or hospital readmissions. CONCLUSIONS The addition of atrial fibrillation ablation to mitral-valve surgery significantly increased the rate of freedom from atrial fibrillation at 1 year among patients with persistent or long-standing persistent atrial fibrillation, but the risk of implantation of a permanent pacemaker was also increased. (Funded by the National Institutes of Health and the Canadian Institutes of Health Research; ClinicalTrials.gov number, NCT00903370.).

[1]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[2]  M. Ezekowitz,et al.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.

[3]  J. Cox.  Mechanical closure of the left atrial appendage: is it time to be more aggressive? , 2013, The Journal of thoracic and cardiovascular surgery.

[4]  E. Soltesz,et al.  Surgical treatment of atrial fibrillation: today's questions and answers. , 2013, Seminars in thoracic and cardiovascular surgery.

[5]  G. Wander,et al.  Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection In Patients With Atrial Fibrillation) trial. , 2013 .

[6]  L. Henry,et al.  The state of surgical ablation for atrial fibrillation in patients with mitral valve disease , 2013, Current opinion in cardiology.

[7]  P. Neužil,et al.  Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial , 2013, Circulation.

[8]  M. Argenziano,et al.  Right atrial lesions do not improve the efficacy of a complete left atrial lesion set in the surgical treatment of atrial fibrillation, but they do increase procedural morbidity. , 2013, The Journal of thoracic and cardiovascular surgery.

[9]  Sean M. O'Brien,et al.  Surgical ablation of atrial fibrillation trends and outcomes in North America. , 2012, The Journal of thoracic and cardiovascular surgery.

[10]  P. Widimsky,et al.  Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study , 2012, European heart journal.

[11]  E. Pokushalov,et al.  Ablation for atrial fibrillation during mitral valve surgery: 1-year results through continuous subcutaneous monitoring. , 2012, Interactive Cardiovascular and Thoracic Surgery.

[12]  M. Vaduganathan,et al.  Midterm survival in patients treated for atrial fibrillation: a propensity-matched comparison to patients without a history of atrial fibrillation. , 2012, The Journal of thoracic and cardiovascular surgery.

[13]  F. Hornero,et al.  64. Implante de marcapasos tras cirugía concomitante de la fibrilación auricular: nuevos factores de riesgo y seguimiento a medio plazo , 2012 .

[14]  David Keane,et al.  2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[15]  Denis Bouchard,et al.  Designing comparative effectiveness trials of surgical ablation for atrial fibrillation: experience of the Cardiothoracic Surgical Trials Network. , 2011, The Journal of thoracic and cardiovascular surgery.

[16]  J. Puskas,et al.  Surgical Ablation for Atrial Fibrillation in Cardiac Surgery a Consensus Statement of the International Society of Minimally Invasive Cardiothoracic Surgery (ISMICS) 2009 , 2010, Innovations.

[17]  C. Blomström-Lundqvist,et al.  A high quality of life is maintained late after Maze III surgery for atrial fibrillation. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[18]  L. Henry,et al.  The Cox-Maze III procedure success rate: comparison by electrocardiogram, 24-hour holter monitoring and long-term monitoring. , 2009, The Annals of thoracic surgery.

[19]  U. V. von Oppell,et al.  Mitral valve surgery plus concomitant atrial fibrillation ablation is superior to mitral valve surgery alone with an intensive rhythm control strategy. , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[20]  O. Alfieri,et al.  Surgery for atrial fibrillation in patients with mitral valve disease: results at five years from the International Registry of Atrial Fibrillation Surgery. , 2008, The Journal of thoracic and cardiovascular surgery.

[21]  Sean M. O'Brien,et al.  Atrial fibrillation correction surgery: lessons from the Society of Thoracic Surgeons National Cardiac Database. , 2008, The Annals of thoracic surgery.

[22]  S. Jensen,et al.  A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery: the SWEDish Multicentre Atrial Fibrillation study (SWEDMAF). , 2007, European heart journal.

[23]  A. Gillinov,et al.  Ablation of atrial fibrillation with concomitant cardiac surgery. , 2007, Seminars in thoracic and cardiovascular surgery.

[24]  K. Mak,et al.  Impact of maze and concomitant mitral valve surgery on clinical outcomes. , 2006, The Annals of thoracic surgery.

[25]  Jeevanantham Rajeswaran,et al.  Surgery for permanent atrial fibrillation: impact of patient factors and lesion set. , 2006, The Annals of thoracic surgery.

[26]  N. Samani,et al.  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial. , 2005, JAMA.

[27]  J. Ramires,et al.  Effectiveness of the Maze Procedure Using Cooled-Tip Radiofrequency Ablation in Patients With Permanent Atrial Fibrillation and Rheumatic Mitral Valve Disease , 2005, Circulation.

[28]  A. Gillinov.  Ablation of atrial fibrillation with mitral valve surgery , 2005, Current opinion in cardiology.

[29]  M. Scanavacca,et al.  Tratamento cirúrgico da fibrilação atrial por isolamento da parede posterior do átrio esquerdo em doentes com valvopatia mitral reumática crônica: um estudo randomizado com grupo controle , 2004 .

[30]  R. Kalil,et al.  Randomized study of surgery for patients with permanent atrial fibrillation as a result of mitral valve disease. , 2004, The Annals of thoracic surgery.

[31]  B. Reichart,et al.  Surgical treatment of permanent atrial fibrillation using microwave energy ablation: a prospective randomized clinical trial. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[32]  U. Ozbek,et al.  Combined radiofrequency modified maze and mitral valve procedure through a port access approach: early and mid-term results. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[33]  N. V. van Hemel,et al.  A randomized study of combining maze surgery for atrial fibrillation with mitral valve surgery. , 2003, The Journal of cardiovascular surgery.

[34]  K. Müller,et al.  Surgical treatment of atrial fibrillation using radiofrequency ablation , 2009 .

[35]  J. Cox,et al.  Impact of the maze procedure on the stroke rate in patients with atrial fibrillation. , 1999, The Journal of thoracic and cardiovascular surgery.

[36]  M. Enriquez-Sarano,et al.  Outcome of valve repair and the Cox maze procedure for mitral regurgitation and associated atrial fibrillation. , 1999, The Journal of thoracic and cardiovascular surgery.

[37]  J Clémenty,et al.  Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 1998, The New England journal of medicine.

[38]  O. Bastien,et al.  Outcome of atrial fibrillation after mitral valve repair. , 1997, The Journal of thoracic and cardiovascular surgery.

[39]  R. Damiano,et al.  The Cox maze IV procedure: predictors of late recurrence. , 2011, The Journal of thoracic and cardiovascular surgery.

[40]  A. Rabinstein.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2010 .

[41]  R. Suri.  Randomized study of surgical isolation of the pulmonary veins for correction of permanent atrial fibrillation associated with mitral valve disease , 2010 .

[42]  M. Scanavacca,et al.  Surgical treatment of atrial fibrillation through isolation of the left atrial posterior wall in patients with chronic rheumatic mitral valve disease. A randomized study with control group. , 2004, Arquivos brasileiros de cardiologia.

[43]  J. Boineau,et al.  The development of the Maze procedure for the treatment of atrial fibrillation. , 2000, Seminars in thoracic and cardiovascular surgery.

[44]  Wolters Kluwer,et al.  Hrs/ehra/ecas Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: a Report of the Heart Rhythm Society (hrs) Task Force , 2022 .